000 | 01175 a2200337 4500 | ||
---|---|---|---|
005 | 20250516020420.0 | ||
264 | 0 | _c20110211 | |
008 | 201102s 0 0 eng d | ||
022 | _a1526-632X | ||
024 | 7 |
_a10.1212/WNL.0b013e318204a3af _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aThompson, Eric M | |
245 | 0 | 0 |
_aThe paradoxical effect of bevacizumab in the therapy of malignant gliomas. _h[electronic resource] |
260 |
_bNeurology _cJan 2011 |
||
300 |
_a87-93 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 | _aBevacizumab |
650 | 0 | 4 |
_aBrain Neoplasms _xdiagnosis |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aGlioma _xdiagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
700 | 1 | _aFrenkel, Eugene P | |
700 | 1 | _aNeuwelt, Edward A | |
773 | 0 |
_tNeurology _gvol. 76 _gno. 1 _gp. 87-93 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0b013e318204a3af _zAvailable from publisher's website |
999 |
_c20491362 _d20491362 |